RenovoRx Inc (RNXT) is a biotechnology company listed on US.
Latest reported RNXT revenue for 2026-06-30 was $1.5M. Net income was -$6.4M. RNXT currently screens at market cap $47.0M.
Use this RNXT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the RNXT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the RNXT SEC filings page. Lician reads the product cache first so this HTML stays unique to RenovoRx Inc even when a live quote feed is slow.
Latest cached year on this hub. Full RNXT income, balance, and cash tables.